Skip to main content

Ernesto Trallero Araguas

Institutions of which they are part

Main researcher
Rheumatology
Vall Hebron Institut de Recerca

Ernesto Trallero Araguas

Institutions of which they are part

Main researcher
Rheumatology
Vall Hebron Institut de Recerca

Projects

Autoimmunitat i malaltia trombòtica

IP: Miguel Vilardell Tarres
Collaborators: Carmen Pilar Simeón i Aznar, Ernesto Trallero Araguas, Roser Solans Laque, Segundo Bujan Rivas, Vicenç Fonollosa Pla, José Ordi Ros, Josefina Cortes Hernandez, Fernando Martínez Valle, Jesus Castro Marrero, Albert Selva O'Callaghan
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 49920
Reference: 2009 SGR 661
Duration: 01/01/2010 - 30/04/2014

Related news

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Related professionals

Rello Saltor, Victoria

Rello Saltor, Victoria

Predoctoral researcher
Infection and immunity in pediatric patients
Read more
Marès Pagès, Roso

Marès Pagès, Roso

Research technician
Translational Molecular Pathology
Read more
Fernández Mondragón, Eva Maria

Fernández Mondragón, Eva Maria

Predoctoral researcher
Multidisciplinary Nursing Research Group
Read more
Tudela Trancoso, Miriam

Tudela Trancoso, Miriam

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.